Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — hormone related health optimization

Breast cancer is not one disease — it encompasses many distinct types with different attributes, degrees of invasiveness and treatment responses. Understanding the difference between invasive and non-invasive cancers, what hormone receptor status means, and which risk factors are modifiable can help women make more informed decisions about screening, lifestyle and hormone health. This article provides a clear, evidence-based overview.

When sex hormone test results show both oestradiol (E2) and progesterone (Pg) within normal ranges, yet symptoms persist, the Pg/E2 ratio provides a critical additional layer of clinical insight. A low ratio points to oestrogen dominance; a high ratio to progesterone dominance — each requiring a different therapeutic response. This article explains how the ratio is calculated, when it is clinically relevant, and how a real-world case illustrates its practical value.

Estrogen dominance — an excess of oestrogen relative to progesterone — is one of the most common hormonal imbalances in women. From heavy periods and mood swings to breast tenderness and weight gain, the symptoms are wide-ranging. Discover the causes, what to test, and how to restore balance.

One in eight women will be diagnosed with breast cancer in their lifetime. But many risk factors are modifiable — including hormone imbalance and excess weight. Discover the two most important actions women can take to reduce breast cancer risk, and how hormone testing can help identify hidden imbalances before they become a problem.

In 1999, Tina Mattern was diagnosed with breast cancer and faced a terrifying choice of conventional treatments. Instead, she discovered the work of Dr. David Zava and ZRT Laboratory, and chose a path of natural hormone balancing, saliva testing and lifestyle change. This is her story — and her happy ending.